CYCLACEL PHARMACEUTICALS INC's ticker is CYCC and the CUSIP is 23254L603. A total of 33 filers reported holding CYCLACEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,073 | -97.4% | 28,400 | -95.7% | 0.00% | -100.0% |
| Q2 2023 | $391,611 | -6.7% | 664,766 | -9.7% | 0.00% | -25.0% |
| Q1 2023 | $419,901 | -18.3% | 736,027 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $513,857 | -42.8% | 770,400 | +25.2% | 0.00% | -50.0% |
| Q3 2022 | $898,000 | +35.2% | 615,200 | +0.1% | 0.01% | +33.3% |
| Q2 2022 | $664,000 | -57.7% | 614,480 | +19.4% | 0.01% | -57.1% |
| Q1 2022 | $1,570,000 | +25.2% | 514,780 | +59.7% | 0.01% | +27.3% |
| Q4 2021 | $1,254,000 | +128.8% | 322,373 | +210.2% | 0.01% | +83.3% |
| Q3 2021 | $548,000 | -9.7% | 103,925 | +1.4% | 0.01% | 0.0% |
| Q2 2021 | $607,000 | -37.6% | 102,525 | -25.0% | 0.01% | -50.0% |
| Q1 2021 | $972,000 | – | 136,725 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,000 | $1,778,000 | 0.97% |
| Affinity Asset Advisors, LLC | 380,000 | $2,702,000 | 0.92% |
| Tri Locum Partners LP | 293,419 | $2,086,000 | 0.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 508,322 | $3,614,000 | 0.28% |
| J. Goldman & Co LP | 357,524 | $2,542,000 | 0.08% |
| Maven Securities LTD | 250,000 | $1,787,000 | 0.08% |
| Ikarian Capital, LLC | 300,000 | $2,133,000 | 0.07% |
| PURA VIDA INVESTMENTS, LLC | 273,958 | $1,948,000 | 0.06% |
| CVI Holdings, LLC | 59,450 | $423,000 | 0.03% |
| Schonfeld Strategic Advisors LLC | 136,725 | $972,000 | 0.01% |